Claude G. Wasterlain

Neurology

11301 Wilshire Blvd
Los Angeles, CA 90073

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Brivaracetam in Combination with Midazolam and Ketamine Reduces Soman-Induced Seizure and Neurodegeneration in Rats.

Brivaracetam in Combination with Midazolam and Ketamine Reduces Soman-Induced Seizure and Neurodegeneration in Rats.

Journal: Neurology international

Published: May 31, 2026

Response: Rethinking GABAergic therapy in neonatal seizures: Beyond Scylla and Charybdis.

Response: Rethinking GABAergic therapy in neonatal seizures: Beyond Scylla and Charybdis.

Journal: Epilepsia open

Published: April 18, 2026

Neonatal seizures and GABAergic drugs: Scylla and Charybdis?

Neonatal seizures and GABAergic drugs: Scylla and Charybdis?

Journal: Epilepsia open

Published: June 18, 2025

Status epilepticus: Is there a stage 1 plus?

Status epilepticus: Is there a stage 1 plus?

Journal: Epilepsia

Published: April 16, 2025

Perampanel as a second-line therapy to midazolam reduces soman-induced status epilepticus and neurodegeneration in rats.

Perampanel as a second-line therapy to midazolam reduces soman-induced status epilepticus and neurodegeneration in rats.

Journal: Epilepsia open

Published: December 23, 2024

Introduction to the special issue on status epilepticus: neuronal injury, plasticity, and therapies; Celebrating the legacy of Dr. Claude G. Wasterlain.

Introduction to the special issue on status epilepticus: neuronal injury, plasticity, and therapies; Celebrating the legacy of Dr. Claude G. Wasterlain.

Journal: Epilepsia open

Published: March 07, 2023

Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats.

Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats.

Journal: The Journal of pharmacology and experimental therapeutics

Published: February 28, 2023

Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats.

Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats.

Journal: The Journal of pharmacology and experimental therapeutics

Published: February 28, 2023

Interictal aggression in rats with chronic seizures after an early life episode of status epilepticus.

Interictal aggression in rats with chronic seizures after an early life episode of status epilepticus.

Journal: Epilepsia open

Published: January 09, 2023

Fifty years of research on status epilepticus: Seizures use hippocampal memory circuits to generate status epilepticus and disrupt brain development.

Fifty years of research on status epilepticus: Seizures use hippocampal memory circuits to generate status epilepticus and disrupt brain development.

Journal: Epilepsy & behavior : E&B

Published: November 21, 2022

Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats.

Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats.

Journal: Epilepsia open

Published: August 02, 2021

Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors.

Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors.

Journal: Neuropharmacology

Published: July 25, 2020

Showing 1-12 of 40

Last Updated: 09/26/2026